
‘I was desperate’: The ads for unlicensed ADHD meds getting banned
Access All: Disability News and Mental Health
00:00
Navigating ADHD Treatment Challenges
This chapter explores the difficulties of monitoring online ads for unlicensed ADHD medications and the role artificial intelligence plays in regulatory efforts. It highlights personal experiences with alternative treatments and the impact of medication shortages, emphasizing the need for consultation with healthcare professionals. The discussion also raises questions about the philosophical implications of treatment claims and the ongoing search for effective remedies amidst desperation for access.
Transcript
Play full episode